Ignite Creation Date:
2025-12-24 @ 5:16 PM
Ignite Modification Date:
2026-04-06 @ 12:51 AM
Study NCT ID:
NCT01863550
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-08
First Post:
2013-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-02-05
Completion Date Type:
ESTIMATED
First Submit Date:
2013-05-06
First Submit QC Date:
None
Study First Post Date:
2013-05-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-04
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED